" Efesovir " (FS-1) for COVID-19, Phase 2

Condition:   Covid19 Intervention:   Drug: Efesovir Sponsor:   Scientific Center for Anti-infectious Drugs, Kazakhstan Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials